#45: GLP-1s Are Rewriting the Gym Business Model - with Bob Thomas copertina

#45: GLP-1s Are Rewriting the Gym Business Model - with Bob Thomas

#45: GLP-1s Are Rewriting the Gym Business Model - with Bob Thomas

Ascolta gratuitamente

Vedi i dettagli del titolo

A proposito di questo titolo

5 provocative, AI-SEO-friendly episode titles (Bob Thomas)
  1. GLP-1s Are Rewriting the Gym Business Model — Here’s the Playbook (Bob Thomas)
  2. Gyms Are Becoming Longevity Centers: GLP-1s, Peptides, HRT & the Truth About Profit
  3. The Longevity Supply Chain: Why Your GLP-1 Partner Can Make or Break Your Brand
  4. Ozempic Didn’t Kill Fitness — It Exposed Weak Retention, Weak Systems, Weak Economics
  5. From 6 to 120 Clubs to Longevity Medicine: What Operators Must Do Before 2026

YouTube show notes (your format)

Today on The Owner Seat Podcast, host Albert Ramos goes behind the curtain of the fastest collision in fitness and wellness right now:

medicine + longevity + the gym business model.

GLP-1s, peptides, hormone optimization, telehealth, and outcomes-driven longevity aren’t “future talk.” They’re here — and operators are either building the bridge… or getting disrupted by it.

My guest is Bob Thomas — CEO & Founder of NexGen MD Scientific and Founder of Nexgen MD 360.

Bob is a 40+ year fitness industry operator who’s seen multiple cycles of hype vs. reality — and he helped shape real scale as a sales/ops executive during Life Time’s growth from 6 clubs to 120 clubs.

Today, he’s building the infrastructure behind longevity medicine the right way:

  1. NexGen MD Scientific: a wholesale supplier serving healthcare providers with hormone solutions built on quality control, compliance, and trust (including a DEA-compliant facility and rigorous standards).
  2. Nexgen MD 360: a doctor-supervised weight management program coordinating with clinics across the U.S. — designed around medication + nutrition + education, not “medication only.”

This episode is for fitness + wellness owners, franchisees, and franchisors who are tired of:

  1. chasing longevity trends without knowing what’s real
  2. partnering with sketchy vendors that create brand + legal risk
  3. guessing on how GLP-1 demand changes acquisition + retention
  4. bolting “medicine” onto fitness and wondering why it doesn’t stick
  5. losing margin to programs with weak ops and no outcomes system

Top topics we cover

1) What’s real vs. hype in GLP-1s, peptides, and HRT

What operators need to understand now — and what narratives are misleading the market.

2) GLP-1s and gyms: the operational shift nobody is modeling

How GLP-1 adoption changes retention, onboarding, programming, and the member lifecycle.

3) “Medication-only” is an outcomes trap

Why the real winners bundle medication with nutrition, education, strength training, and adherence systems.

4) The longevity supply chain: quality, compliance, and...

Ancora nessuna recensione